Physicians Realty Trust Declares Quarterly Cash Dividend and Announces Date for the Third Quarter 2023 Earnings Release and Conference Call

Rhea-AI Summary

Physicians Realty Trust (NYSE: DOC) declares quarterly cash dividend of $0.23 per share. Celebrates 10th anniversary of IPO. Q3 2023 earnings release and conference call scheduled for November 3, 2023.

Positive

• Quarterly dividend declared
• Solidified position as trusted partner
• 10th anniversary of IPO

Negative

• None.

MILWAUKEE--(BUSINESS WIRE)-- Physicians Realty Trust (NYSE: DOC) (the “Company”) announced today that the Company’s Board of Trustees has authorized, and the Company has declared, a quarterly cash dividend of $0.23 per common share and unit for the quarter ending September 30, 2023. “We are proud to declare and pay our 41^st consecutive quarterly dividend. This quarter, we celebrated a momentous milestone as we celebrated the 10^th anniversary of our IPO on the New York Stock Exchange on July 19, 2013. Through strategic investments in outpatient medical facilities and disciplined financial management, we believe the Company has solidified its position as a trusted partner for investors seeking stable, long-term returns. We look forward to sharing more about our third quarter 2023 results in our earnings release and related conference call, scheduled for November 3, 2023,” said John T. Thomas, the Company’s President and Chief Executive Officer.

The dividend will be payable on October 17, 2023, to common shareholders and unit holders of record on October 3, 2023.

Earnings Release and Conference Call Information

The Company announced it will release its financial results for the third quarter ended September 30, 2023, before the market opens on November 3, 2023, and will hold a conference call on this day at 10:00 a.m. ET to discuss the financial results and provide a company update. The conference call will be hosted by President and Chief Executive Officer John Thomas, Executive VP and Chief Financial Officer Jeff Theiler, Executive VP of Asset Management Mark Theine, and Chief Accounting and Administrative Officer John Lucey.

The conference call can be accessed by dialing (877) 407-0784 from within the U.S. or (201) 689-8560 for international callers. Participants can reference the Physicians Realty Trust Third Quarter Earnings Call. The conference call will also be available via a live listen-only webcast and can be accessed through the Investor Relations section of the Company’s website, www.docreit.com. A replay of the conference call will be available beginning November 3, 2023, at 2:00 p.m. ET until December 3, 2023, at 11:59 p.m. ET, by dialing (844) 512-2921 (U.S.) or (412) 317-6671 (International); passcode: 13741282. A replay of the webcast will also be accessible on the Investor Relations website for one year following the event. Beginning November 3, 2023, the Company’s supplemental information package for the third quarter 2023 also will be accessible through the Investor Relations section of the Company’s website under the “Supplemental Information” tab.

About Physicians Realty Trust

Physicians Realty Trust is a self-managed health care real estate company organized to acquire, selectively develop, own, and manage health care properties that are leased to physicians, hospitals and health care delivery systems. The Company invests in real estate that is integral to providing high quality health care. The Company is a Maryland real estate investment trust and has elected to be taxed as a REIT for U.S. federal income tax purposes. The Company conducts its business through an UPREIT structure in which its properties are owned by the Operating Partnership, directly or through limited partnerships, limited liability companies or other subsidiaries.

Forward-Looking Statements

This press release contains statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, “continue”, “intend”, and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward looking statements may include statements regarding the Company’s strategic and operational plans, the Company’s ability to generate internal and external growth, the future outlook, anticipated cash returns, cap rates or yields on properties, anticipated closing of property acquisitions, ability to execute its business plan, and the impact of the COVID-19 pandemic on the Company’s business. While forward-looking statements reflect our good faith beliefs, they are not guarantees of future performance. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. These forward-looking statements are subject to various risks and uncertainties, not all of which are known to the Company and many of which are beyond the Company’s control, which could cause actual results to differ materially from such statements. These risks and uncertainties are described in greater detail in the Company’s filings with the Securities and Exchange Commission (the “Commission”), including, without limitation, the Company’s annual and periodic reports and other documents filed with the Commission. Unless legally required, the Company disclaims any obligation to update any forward-looking statements after the date of this release, whether as a result of new information, future events or otherwise. For a discussion of factors that could impact the Company’s results, performance, or transactions, see Part I, Item 1A (Risk Factors) of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230921217848/en/

Physicians Realty Trust

John T. Thomas

President and CEO

(214) 549-6611

jtt@docreit.com

Jeffrey N. Theiler

Executive Vice President and CFO

(414) 367-5610

jnt@docreit.com

Source: Physicians Realty Trust